• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation.

作者信息

Petry A, Wulf H, Baumgärtel M

机构信息

Clinic for Anaesthesiology and Intensive Care Medicine, University of Kiel, Germany.

出版信息

Anaesthesia. 1995 Apr;50(4):312-6. doi: 10.1111/j.1365-2044.1995.tb04606.x.

DOI:10.1111/j.1365-2044.1995.tb04606.x
PMID:7747847
Abstract

The study was performed to investigate the different effects of ketanserin and urapidil on haemodynamics, kidney function and plasma catecholamine and aldosterone levels. Forty male patients scheduled for myocardial revascularisation were assigned at random to two groups: group K received ketanserin, group U received urapidil. Anaesthesia consisted of fentanyl, flunitrazepam and pancuronium. Haemodynamic variables were evaluated at eight predefined time points of the operation. Creatinine and free-water clearance as well as plasma levels of adrenaline, noradrenaline and aldosterone were measured in three different periods of the operation. While the groups showed no clinically relevant differences in the haemodynamic variables and the hormone plasma concentrations, the creatinine clearance in group K was slightly increased in the period after cardiopulmonary bypass. Both ketanserin and urapidil prevented hypertension even in the presence of elevated catecholamine plasma levels during and after cardiopulmonary bypass.

摘要

相似文献

1
The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation.
Anaesthesia. 1995 Apr;50(4):312-6. doi: 10.1111/j.1365-2044.1995.tb04606.x.
2
Computer aided monitor-data processing (CAMP). A landmark for unbiased gauging of anaesthetic courses?计算机辅助监测数据处理(CAMP)。它是无偏评估麻醉过程的一个里程碑吗?
J Clin Monit Comput. 1998 Feb;14(2):101-12. doi: 10.1023/a:1007412615313.
3
Ketanserin and urapidil during myocardial revascularisation.心肌血运重建术中的酮色林和乌拉地尔。
Anaesthesia. 1995 Dec;50(12):1100. doi: 10.1111/j.1365-2044.1995.tb05977.x.
4
A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.乌拉地尔与酮色林用于冠状动脉搭桥术后高血压患者的随机多中心双盲对照研究。
J Cardiothorac Vasc Anesth. 1997 Oct;11(6):729-36. doi: 10.1016/s1053-0770(97)90166-x.
5
Ketanserin and the cardiovascular system. 2. A study of its effects in patients undergoing myocardial revascularisation.酮色林与心血管系统。2. 对接受心肌血运重建术患者的疗效研究。
Anaesthesia. 1986 Jul;41(7):712-6. doi: 10.1111/j.1365-2044.1986.tb12837.x.
6
Ketanserin and the cardiovascular system. 1. Modification of the effects of pressor amines in patients undergoing myocardial revascularisation.酮色林与心血管系统。1. 对接受心肌血运重建术患者升压胺类药物作用的影响
Anaesthesia. 1986 Jul;41(7):708-11. doi: 10.1111/j.1365-2044.1986.tb12836.x.
7
Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.围手术期α1受体阻滞剂对嗜铬细胞瘤腹腔镜手术期间血流动力学控制的影响。
Br J Anaesth. 2004 Apr;92(4):512-7. doi: 10.1093/bja/aeh083. Epub 2004 Feb 6.
8
[Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients].
Anaesthesist. 1985 Sep;34(9):435-45.
9
[Efficacy of a single dose of urapidil for preventing arterial hypertension during the pre-bypass period in coronary surgery].[单剂量乌拉地尔预防冠状动脉手术体外循环前期动脉高血压的疗效]
Rev Esp Anestesiol Reanim. 2000 Oct;47(8):337-42.
10
Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy.
Anaesthesia. 1986 May;41(5):505-10. doi: 10.1111/j.1365-2044.1986.tb13275.x.

引用本文的文献

1
Urapidil. A reappraisal of its use in the management of hypertension.乌拉地尔。对其在高血压治疗中应用的重新评估。
Drugs. 1998 Nov;56(5):929-55. doi: 10.2165/00003495-199856050-00016.